Summary
The product Anavamed 10, manufactured by Deus Medical, underwent independent testing to confirm its potency and authenticity. The sample, identified by batch number DM24100, was submitted by DEUSPOWER.SHOP and analyzed by Janoshik Analytical. The analysis confirmed the presence of Oxandrolone, with measured concentrations of 10.13 mg and 10.31 mg in two separate pills, closely aligning with the labeled 10 mg dosage.
The testing process began on 18 November 2020, with the sample received on the same day, and analysis completed on 20 November 2020. These results confirm accurate dosing, but third-party testing remains crucial for verifying consistency across different production batches.
Detailed Report
Product Overview
- Manufacturer: Deus Medical
- Product Name: Anavamed 10
- Active Ingredient: Oxandrolone
- Batch Number: DM24100 (Manufactured: 11/2020)
- Expiration Date: Not provided
- Delivery Method: Oral
Sample Acquisition and Testing
- Task Number: #09126
- Testing Ordered: 18 November 2020
- Sample Received: 18 November 2020
- Analysis Conducted By: Janoshik Analytical
- Product Submitted By: DEUSPOWER.SHOP
- Analysis Paid For By: DEUSPOWER.SHOP
Testing Results
- Specification: 10 mg (as stated on the label)
- Measured Concentration:
- First Pill: 10.13 mg
- Second Pill: 10.31 mg
- Accuracy: 101.3% – 103.1% of the label claim
- Variance: +0.13 & +0.31
Verification Details
- Verification URL: https://janoshik.com/tests/09126_Y9QQNVC2E9ST
Evaluation of Reseller-Submitted Testing
While this test confirms strong accuracy, it is essential to recognize that this sample was submitted and funded by DEUSPOWER.SHOP, a reseller. Resellers may test select batches that exhibit high quality, meaning this might not reflect overall consistency across multiple production lots.
For a full assessment of product reliability, independent third-party validation across different batches is advised.
Conclusion
The analysis confirms that Anavamed 10 by Deus Medical is accurately dosed, with Oxandrolone concentrations slightly above the label claim. The small variance of +1.3% to +3.1% is within acceptable pharmaceutical tolerances, indicating strong manufacturing quality control.
However, as this test was submitted by a reseller, further independent testing is recommended to ensure product consistency across different batches.
This report serves as an educational resource to help consumers make informed decisions regarding Oxandrolone-containing products.
Disclaimer
This report is published for educational and harm reduction purposes. While reseller-submitted testing can provide useful insights, it is always best practice to validate product consistency through independent sources.
Consumers should verify product reliability before making purchasing decisions.
